文献速递骨显像与常规 SPECT肿瘤 PET/CT放射性药物与辐射防护

脊柱椎间盘炎的影像学:进展更新

Imaging of Spondylodiscitis: An Update.
PubMed 文献 · Semin Nucl Med · 2022-12-13

脊柱椎间盘炎是椎体或椎间盘的感染,可累及硬膜外间隙、后柱及椎旁软组织。磁共振增强扫描是首选影像方法,但评估治疗反应作用有限;当磁共振不可用或无法诊断时,核素显像是有用的替代。18F-FDG 是核素检查首选,敏感、阴性预测值高,可区分退变与感染性终板异常,并在对比研究中优于骨显像和镓-67 显像。

要点

  • 磁共振增强扫描是脊柱椎间盘炎的首选影像方法,但评估治疗反应作用有限。
  • 18F-FDG 是核素检查首选,敏感、阴性预测值高,可区分退变与感染性终板异常。
  • 骨显像早期和老年患者可出现假阴性,且不能检出常伴随的软组织感染。

核心结论

  • 18F-FDG 显像是脊柱椎间盘炎的核素检查首选,敏感、阴性预测值高,可区分退变与感染性终板异常,并在对比研究中优于骨显像和镓-67 显像。
  • 磁共振增强扫描是首选影像方法,但评估治疗反应作用有限;当磁共振不可用或无法诊断时,核素显像是有用的替代。
  • 镓-67 柠檬酸盐可提高骨显像特异性、较骨显像更早检出感染、可能更敏感(尤其老年患者)并可识别伴随软组织感染,但给药后需延迟 2-3 天、图像质量差、患者辐射剂量较高且药物可及性下降。
  • 骨显像常作筛查,但感染早期和老年患者可出现假阴性,且不能检出常伴随或模拟脊柱椎间盘炎的软组织感染。
  • 标记白细胞显像对脊柱椎间盘炎诊断无作用。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 磁共振增强扫描是脊柱椎间盘炎的首选影像方法,因具有高敏感性和高特异性。
  • 静脉注射钆对比剂可更好显示软组织和骨脓肿范围。
  • 骨显像在感染早期和老年患者可出现假阴性,且不能检出常伴随或模拟脊柱椎间盘炎的软组织感染。
  • 镓-67 柠檬酸盐可提高骨显像特异性,较骨显像更早检出感染,可能更敏感(尤其老年患者),并识别伴随软组织感染;SPECT 和 SPECT/CT 可提高准确性。
  • 18F-FDG 检查可在一天内完成,敏感、阴性预测值高,可可靠区分退变与感染性椎体终板异常,并可能为监测治疗反应提供客观手段。

关键数值与推荐

  • 磁共振增强扫描是首选影像方法;静脉注射钆对比剂可更好显示软组织和骨脓肿范围。
  • 18F-FDG 是核素检查首选,敏感、阴性预测值高,可区分退变与感染性终板异常,并在对比研究中优于骨显像和镓-67 显像。
  • 镓-67 柠檬酸盐给药后需延迟 2-3 天,图像质量差,患者辐射剂量相对较高,且药物可及性不如从前。
  • 铟-111 生物素可准确诊断脊柱椎间盘炎,但该放射性药物从未商业供应。
  • 镓-68 柠檬酸盐和 99mTc 标记抗菌肽已有研究,但其在脊柱椎间盘炎诊断中的作用尚未确立。

临床怎么用

  • 磁共振增强扫描作为脊柱椎间盘炎首选影像方法;当磁共振不能进行或无法诊断时,核素显像是有用的替代。
  • 18F-FDG 显像是脊柱椎间盘炎的核素检查首选。
  • 骨显像可作筛查,但需注意感染早期和老年患者可出现假阴性,且不能检出软组织感染。
  • 镓-67 柠檬酸盐可提高骨显像特异性并识别伴随软组织感染,但需延迟 2-3 天、图像质量差、辐射剂量较高且可及性下降。
  • 标记白细胞显像对脊柱椎间盘炎诊断无作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Spondylodiscitis is an infection of the vertebral body and/or intervertebral disc, which can also involve the epidural space, posterior elements, and paraspinal soft tissues. Due to high morbidity and mortality, prompt diagnosis and treatment of spondylodiscitis is critical. However, diagnosis can be challenging due to nonspecific signs and symptoms. Magnetic resonance imaging with and without contrast is the imaging modality of choice due to high sensitivity and specificity. Intravenous administration of gadolinium contrast can better demonstrate the extent of soft tissue and bone abscesses. However, magnetic resonance imaging is less useful in the evaluation of treatment response. When magnetic resonance imaging cannot be performed or is not diagnostic, radionuclide imaging is a useful alternative. Although bone scintigraphy frequently is used as a screening test, false negative results can occur early in the course of the infection and in the elderly. This test is not useful for detecting the soft tissue infections that often accompany or mimic spondylodiscitis. Gallium-67 citrate improves the specificity of the bone scan, can detect infection earlier than the bone scan, may be more sensitive, especially in elderly patients, and identifies accompanying soft tissue infection. Performing SPECT and SPECT/CT improve accuracy. The 2-3 day delay between radiopharmaceutical administration, poor image quality, and relatively high patient radiation dose are significant disadvantages of gallium-67. Furthermore gallium-67 is no longer as readily available as it once was. 18F-FDG imaging is the radionuclide test of choice for spondylodiscitis. The procedure, completed in one day, is sensitive, has a high negative predictive value, and reliably differentiates degenerative from infectious vertebral body end-plate abnormalities. 18F-FDG has outperformed bone and gallium-67 imaging in comparative studies. 18F-FDG may be able to provide an objective means for monitoring response to treatment. The potential of other agents for diagnosing spondylodiscitis has been studied. Although indium-111biotin accurately diagnoses spondylodiscitis, this radiopharmaceutical has never been commercially available. Gallium-68 citrate and 99mTc-radiolabeled antimicrobial peptides have been investigated, but their role in the diagnosis of spondylodiscitis has not been established. Labeled leukocyte scintigraphy has no role in the diagnosis of spondylodiscitis.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Raghavan M, Palestro CJ. Imaging of Spondylodiscitis: An Update. Semin Nucl Med. 2022. PMID: 36522190. doi:10.1053/j.semnuclmed.2022.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。